IntReALL 2020 started

IntReALL 2020 - the International Study for Treatment of Childhood Relapsed ALL 2020

An EU funded Project started on May 01 2023.

Relapse of acute lymphoblastic leukemia (ALL) remains a leading cause of mortality in childhood cancer.

IntReALL 2020 will conduct randomized and historically controlled trials in children with relapsed B-cell precursor (BCP) ALL with the aim to replace toxic chemotherapy with better tolerated and more efficacious immunotherapeutic drugs.

More soon here.